1. Home
  2. EVO vs MASS Comparison

EVO vs MASS Comparison

Compare EVO & MASS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evotec SE

EVO

Evotec SE

N/A

Current Price

$1.59

Market Cap

568.6M

Sector

Health Care

ML Signal

N/A

Logo 908 Devices Inc.

MASS

908 Devices Inc.

N/A

Current Price

$9.71

Market Cap

498.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EVO
MASS
Founded
1993
2012
Country
Germany
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
568.6M
498.1M
IPO Year
2007
2020

Fundamental Metrics

Financial Performance
Metric
EVO
MASS
Price
$1.59
$9.71
Analyst Decision
Buy
Strong Buy
Analyst Count
3
6
Target Price
$4.48
★ $14.00
AVG Volume (30 Days)
65.9K
★ 365.2K
Earning Date
11-05-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 125.47
EPS
★ N/A
N/A
Revenue
N/A
★ $56,197,000.00
Revenue This Year
N/A
$23.13
Revenue Next Year
$18.90
$18.66
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$1.33
$5.03
52 Week High
$3.87
$13.35

Technical Indicators

Market Signals
Indicator
EVO
MASS
Relative Strength Index (RSI) 48.34 40.13
Support Level $1.50 $9.32
Resistance Level $1.61 $10.88
Average True Range (ATR) 0.06 0.93
MACD 0.01 -0.20
Stochastic Oscillator 28.13 12.84

Price Performance

Historical Comparison
EVO
MASS

About EVO Evotec SE

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

About MASS 908 Devices Inc.

908 Devices Inc develops a suite of purpose-built handheld devices for point-of-need chemical analysis. Leveraging mass spectrometry, optical spectroscopy, analytics and machine learning technologies, the company makes devices that are smaller and more accessible than conventional laboratory instruments. Its devices, including MX908, ThreatID, XplorIR and VipIR, are used to analyze unknown materials and provide actionable answers in health, safety and defense technology applications, addressing the fentanyl and illicit drug crisis, toxic carcinogen exposure and security threats. The company reimagines mass spectrometry technology by developing smaller, lower-cost and simpler-to-operate devices compared to conventional instruments, and generates maximum revenue from the United States.

Share on Social Networks: